Edgewell (EPC) CEO reports vesting, tax withholding and new RSUs
Rhea-AI Filing Summary
Edgewell Personal Care (EPC) reported insider equity transactions by Chief Executive Officer and Director Rod R. Little. On 11/13/2025, 58,612 performance stock equivalents vested and converted into shares of common stock at an exercise price of $0. On the same date, 27,167 shares were withheld to cover tax liabilities at a price of $18.39 per share, leaving Little with 365,818 shares of common stock held directly.
In a related derivative transaction, the original performance award was 166,038 shares, of which only 58,612 vested based on performance criteria, with 107,426 shares cancelled. On 11/14/2025, Little received a grant of 103,420 restricted stock equivalents at an exercise price of $0. One-third of this award will vest and convert into Edgewell common stock on each of 11/14/2026, 11/14/2027, and 11/14/2028, subject to continued employment or certain other events.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Equivalents 11/14/2025 | 103,420 | $0.00 | -- |
| Exercise | Performance Stock Equivalents 11-11-2022 | 58,612 | $0.00 | -- |
| Exercise | Common Stock | 58,612 | $0.00 | -- |
| Tax Withholding | Common Stock | 27,167 | $18.39 | $500K |
Footnotes (1)
- Shares withheld as payment of a tax liability on vesting of performance stock equivalents. Performance Stock Equivalents vested and converted into shares of EPC common stock on 11/13/2025. The original award was 166,038 shares; only 58,612 vested in accordance with the performance criteria. The remaining 107,426 shares were cancelled. One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.
FAQ
What insider transaction did EPC's CEO Rod R. Little report on this Form 4?
Rod R. Little reported that on 11/13/2025, 58,612 performance stock equivalents vested and converted into shares of Edgewell Personal Care (EPC) common stock at an exercise price of $0. He also reported a new grant of 103,420 restricted stock equivalents on 11/14/2025.
What happened to the CEO's performance stock equivalents in this EPC Form 4?
The original performance stock equivalents award was 166,038 shares. On 11/13/2025, 58,612 vested and converted into EPC common stock, while the remaining 107,426 shares were cancelled because the performance criteria were not met.
What are the terms of the 103,420 restricted stock equivalents granted to EPC's CEO?
The filing reports that 103,420 restricted stock equivalents were granted on 11/14/2025 at an exercise price of $0. One-third of these will vest and convert into Edgewell common stock on each of 11/14/2026, 11/14/2027, and 11/14/2028, if the reporting person remains employed or in certain other events such as death, disability, change in control, or specified termination events.
Did the EPC CEO still hold any performance stock equivalents after these transactions?
No. Following the vesting and conversion of 58,612 performance stock equivalents into EPC common stock on 11/13/2025 and the cancellation of the remaining 107,426, the filing shows 0 performance stock equivalents remaining beneficially owned.